GB1430684A - Prolonged release lozenges - Google Patents

Prolonged release lozenges

Info

Publication number
GB1430684A
GB1430684A GB2973173A GB2973173A GB1430684A GB 1430684 A GB1430684 A GB 1430684A GB 2973173 A GB2973173 A GB 2973173A GB 2973173 A GB2973173 A GB 2973173A GB 1430684 A GB1430684 A GB 1430684A
Authority
GB
United Kingdom
Prior art keywords
active ingredient
methyl cellulose
june
humidity
prolonged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2973173A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB1430684A publication Critical patent/GB1430684A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB2973173A 1972-06-26 1973-06-22 Prolonged release lozenges Expired GB1430684A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26645272A 1972-06-26 1972-06-26

Publications (1)

Publication Number Publication Date
GB1430684A true GB1430684A (en) 1976-03-31

Family

ID=23014648

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2973173A Expired GB1430684A (en) 1972-06-26 1973-06-22 Prolonged release lozenges

Country Status (8)

Country Link
JP (1) JPS4954519A (de)
BR (1) BR7304698D0 (de)
CA (1) CA1018456A (de)
DE (1) DE2332484C2 (de)
DK (1) DK146434C (de)
FR (1) FR2190409B1 (de)
GB (1) GB1430684A (de)
NL (1) NL183808C (de)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133284A (en) * 1983-01-07 1984-07-25 English Grains Limited Resilient pharmaceutical unit for treating mouth ulcers
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US5316773A (en) * 1990-07-19 1994-05-31 Otsuka Pharmaceutical Co., Ltd. Particulate preparation containing a flourracil derivative and hydroxypropylmethyl-cellulose
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
WO2004028507A1 (en) * 2002-09-24 2004-04-08 Akzo Nobel N.V. Method to improve pharmaceutical tablets having a matrix of cellulose ether
US8298581B2 (en) 2003-03-26 2012-10-30 Egalet A/S Matrix compositions for controlled delivery of drug substances
US8609143B2 (en) 2001-09-21 2013-12-17 Egalet Ltd. Morphine polymer release system
US8617605B2 (en) 2001-09-21 2013-12-31 Egalet Ltd. Polymer release system
US8877241B2 (en) 2003-03-26 2014-11-04 Egalet Ltd. Morphine controlled release system
US9005660B2 (en) 2009-02-06 2015-04-14 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
US9023394B2 (en) 2009-06-24 2015-05-05 Egalet Ltd. Formulations and methods for the controlled release of active drug substances
US9044402B2 (en) 2012-07-06 2015-06-02 Egalet Ltd. Abuse-deterrent pharmaceutical compositions for controlled release
US9642809B2 (en) 2007-06-04 2017-05-09 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43437B (en) * 1976-05-05 1989-08-31 Lowey Hans Process for obtaining tablets containing an active component with long lasting effect
FR2455459A1 (fr) * 1979-05-02 1980-11-28 Sertog Procede d'obtention d'une matrice contenant un principe actif et le liberant progressivement
US4357469A (en) 1979-06-14 1982-11-02 Forest Laboratories, Inc. Carrier base material for prolonged release therapeutic compositions
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
JPH0729927B2 (ja) * 1983-04-09 1995-04-05 日研化学株式会社 テオフィリン徐放性製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
JPH07112934A (ja) * 1993-10-15 1995-05-02 Taiyo Yakuhin Kogyo Kk ペントキシフィリンの徐放化製剤およびその製法
EP0746310B1 (de) * 1994-02-23 1998-11-18 BM Research A/S Zusammensetzung mit gesteuerter freisetzung
DK1067910T3 (da) 1998-04-03 2004-10-04 Egalet As Komposition med styret afgivelse
US20040151772A1 (en) 2002-11-08 2004-08-05 Egalet A/S Controlled release carvedilol compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1171691A (en) * 1967-02-24 1969-11-26 Forest Laboratories Lond-Acting Oral Carrier
GB1279214A (en) * 1970-01-22 1972-06-28 Forest Laboratories Long-acting oral carrier

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133284A (en) * 1983-01-07 1984-07-25 English Grains Limited Resilient pharmaceutical unit for treating mouth ulcers
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US5316773A (en) * 1990-07-19 1994-05-31 Otsuka Pharmaceutical Co., Ltd. Particulate preparation containing a flourracil derivative and hydroxypropylmethyl-cellulose
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US8808745B2 (en) 2001-09-21 2014-08-19 Egalet Ltd. Morphine polymer release system
US9694080B2 (en) 2001-09-21 2017-07-04 Egalet Ltd. Polymer release system
US8609143B2 (en) 2001-09-21 2013-12-17 Egalet Ltd. Morphine polymer release system
US8617605B2 (en) 2001-09-21 2013-12-31 Egalet Ltd. Polymer release system
US9707179B2 (en) 2001-09-21 2017-07-18 Egalet Ltd. Opioid polymer release system
WO2004028507A1 (en) * 2002-09-24 2004-04-08 Akzo Nobel N.V. Method to improve pharmaceutical tablets having a matrix of cellulose ether
US9375428B2 (en) 2003-03-26 2016-06-28 Egalet Ltd. Morphine controlled release system
US8298581B2 (en) 2003-03-26 2012-10-30 Egalet A/S Matrix compositions for controlled delivery of drug substances
US8877241B2 (en) 2003-03-26 2014-11-04 Egalet Ltd. Morphine controlled release system
US9884029B2 (en) 2003-03-26 2018-02-06 Egalet Ltd. Morphine controlled release system
US9642809B2 (en) 2007-06-04 2017-05-09 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
US9358295B2 (en) 2009-02-06 2016-06-07 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
US9005660B2 (en) 2009-02-06 2015-04-14 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
US9023394B2 (en) 2009-06-24 2015-05-05 Egalet Ltd. Formulations and methods for the controlled release of active drug substances
US9044402B2 (en) 2012-07-06 2015-06-02 Egalet Ltd. Abuse-deterrent pharmaceutical compositions for controlled release
US9549899B2 (en) 2012-07-06 2017-01-24 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release

Also Published As

Publication number Publication date
NL183808B (nl) 1988-09-01
DE2332484A1 (de) 1974-01-10
DE2332484C2 (de) 1984-11-15
FR2190409A1 (de) 1974-02-01
DK146434B (da) 1983-10-10
DK146434C (da) 1984-03-19
BR7304698D0 (pt) 1974-09-24
JPS4954519A (de) 1974-05-27
FR2190409B1 (de) 1977-04-15
NL7308859A (de) 1973-12-28
NL183808C (nl) 1989-02-01
CA1018456A (en) 1977-10-04

Similar Documents

Publication Publication Date Title
GB1430684A (en) Prolonged release lozenges
ES430431A1 (es) Varistor de oxido metalico.
GB1421964A (en) Process for the production of sustained release pharmaceutical preparations
KR880010757A (ko) 제약정제, 제약과립 및 그의 제조방법
CA2018167A1 (en) Sustained release pharmaceutical tablet
ES8504453A1 (es) Procedimiento para producir una tableta divisible con liberacion retardada del principio activo
GB1390311A (en) Timed-release pharmaceutical preparations
GB1171691A (en) Lond-Acting Oral Carrier
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
EP0021009A3 (en) Preparation for substances, process for its production and its utilisation
GB1380171A (en) Medicinal tablets
CA988424A (en) Pharmaceutical compositions of n-acylaminophenol in a suitable form for tabletting
GB1480175A (en) Compositions in the form of coated tablets
ES412098A1 (es) Procedimiento para la produccion de inhibidores de sacara- sa.
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
DE3274185D1 (en) Medicinal preparations for glycoside-hydrolase inhibitors
GB1443023A (en) Process for preparing tablets and pills
GB862376A (en) Sustained release pharmaceutical tablet
GB1439240A (en) Chewable aspirin tablet
IE39283B1 (en) Tablet formulation
FR2175853A1 (en) Oral cmpns for tobacco dependence - contg avena extracts dispersing rapidly in the mouth
KR900009060A (ko) 트리메부틴 기재 서방형 조성물 및 그 제조 방법
JPS5344617A (en) Drug composition
GB1473315A (en) Freeze-dried flavoured pharmaceuticals
CA976171A (en) 4,5-bis-trifluoromethylimino derivatives of thiazolidines, and to a process for their preparation

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years

Effective date: 19930621